| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-06 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 2e-05 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.11 | 8e-05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.23 | 0.0002 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |